Structural basis for the activation and inhibition of the UCH37 deubiquitylase.
about
Substrate specificity of the ubiquitin and Ubl proteasesThe business of deubiquitination - location, location, locationMolecular architecture of polycomb repressive complexesStructure of the Rpn13-Rpn2 complex provides insights for Rpn13 and Uch37 as anticancer targetsThe BAP1/ASXL2 Histone H2A Deubiquitinase Complex Regulates Cell Proliferation and Is Disrupted in Cancer.Gates, Channels, and Switches: Elements of the Proteasome MachineIsolation and Characterization of RNA Aptamers against a Proteasome-Associated Deubiquitylating Enzyme UCH37.Using protein motion to read, write, and erase ubiquitin signals.The Proteasome Ubiquitin Receptor hRpn13 and Its Interacting Deubiquitinating Enzyme Uch37 Are Required for Proper Cell Cycle ProgressionUbiquitin C-terminal hydrolase37 regulates Tcf7 DNA binding for the activation of Wnt signalling.Entropic stabilization of a deubiquitinase provides conformational plasticity and slow unfolding kinetics beneficial for functioning on the proteasomeStructural disorder and its role in proteasomal degradation.Mechanisms of regulation and diversification of deubiquitylating enzyme function.BAP1/ASXL1 recruitment and activation for H2A deubiquitination.Ubiquitin recognition by the proteasome.Protein Degradation Systems as Antimalarial Therapeutic Targets.The role of ubiquitin-dependent segregase p97 (VCP or Cdc48) in chromatin dynamics after DNA double strand breaks.Identification of deubiquitinase targets of isothiocyanates using SILAC-assisted quantitative mass spectrometry.SGTA interacts with the proteasomal ubiquitin receptor Rpn13 via a carboxylate clamp mechanism.Structures of Rpn1 T1:Rad23 and hRpn13:hPLIC2 Reveal Distinct Binding Mechanisms between Substrate Receptors and Shuttle Factors of the Proteasome.Ubiquitin recognition of BAP1: understanding its enzymatic function.Meddling with Fate: The Proteasomal Deubiquitinating Enzymes.UCHL5 expression associates with improved survival in lymph-node-positive rectal cancer.Nuclear ubiquitin C-terminal hydrolase L5 expression associates with increased patient survival in pancreatic ductal adenocarcinoma.Ubiquitin carboxyl-terminal hydrolases: involvement in cancer progression and clinical implications.The deubiquitinase UCHL5/UCH37 positively regulates Hedgehog signaling by deubiquitinating Smoothened.Ubiquitin carboxyl-terminal hydrolase isozyme L5 inhibits human glioma cell migration and invasion via downregulating SNRPF.Structure and energetics of pairwise interactions between proteasome subunits RPN2, RPN13, and ubiquitin clarify a substrate recruitment mechanism.A fluorescence polarization-based competition assay for measuring interactions between unlabeled ubiquitin chains and UCH37•RPN13.Positive cytoplasmic UCHL5 tumor expression in gastric cancer is linked to improved prognosis.Monoubiquitination of ASXLs controls the deubiquitinase activity of the tumor suppressor BAP1A bidentate Polycomb Repressive-Deubiquitinase complex is required for efficient activity on nucleosomesQuantitative Proteomic Analysis Reveals That Arctigenin Alleviates Concanavalin A-Induced Hepatitis Through Suppressing Immune System and Regulating Autophagy
P2860
Q26751372-CC2EDC87-6E4C-49A5-9167-8E22A57BBE8AQ26766125-B4434184-7791-4F37-8B97-2E6DDEEF0E53Q33364784-7FDD559D-4175-4048-956A-A2E40E8E43A4Q33862782-40881B00-3992-48E4-A215-940C4EAF8D5CQ34496129-9CAEDC60-EC67-4AE6-84A9-8B6DCBB252ACQ35862786-3093DB49-F8C3-4C67-97D6-CC31F486792FQ36216365-51A11840-5CAE-4911-9914-211B9CDEA9CDQ36283663-798E962B-B3DD-4A80-998E-D493743D90C8Q36884720-C2365344-D615-448C-B02B-9FC04FE9DA1DQ37642658-D777318C-551A-4D4B-914C-848B8DFD86B6Q37719492-2BC3526E-C7B3-4318-9B5D-44471808913DQ38557562-FD6BD746-6CC1-4655-8CF8-4B05193852ACQ38687124-6BAA8A68-0F56-4445-9340-B74D551A46C3Q38806099-02A94A4A-A94F-4440-B5BF-85E62BBFDA96Q39077452-9B9D191F-10FF-4755-8550-F6528BE404A2Q39422863-BCA55D07-AB7F-45D1-901B-3A8FF8EB18CCQ41567964-4422CB77-562C-4E45-8210-27D32D665E3DQ41612750-DB4A4C16-E014-4537-B763-951556DF8F1BQ42371745-9522AAD8-536D-486E-A188-4CB24BC4DB36Q42382149-E2BAE3FA-B1B6-498A-ABAB-ADE2F5F78F37Q47155655-76026278-F75F-4BBA-A704-737DCD268DB3Q47292178-514153BD-3120-459C-AAB4-67F713AEF007Q47328929-790DFAE4-1917-4BE8-9AD1-97B375502FCBQ47336139-50229449-07CC-4745-B96C-3A2669885DA3Q47592158-A95B35B0-051C-4E39-AC68-E3103B0A344DQ47676569-82A795E1-1600-4EE8-ADC1-8203B81BB0C9Q47838764-C987087F-3508-4910-B4C3-162759671905Q51035419-02CC44B2-B8B8-4B01-924A-725E087C018DQ52308769-F138DB78-5644-4E2D-A903-F007A991D772Q52688319-5BAF0B49-DCE9-4177-95C6-37CEB44E3267Q57804762-44ABF82F-40A2-47EC-A4D3-1F2032E11A7EQ58695813-BAE06F0C-5D47-4868-A569-452262F3992BQ58773456-03D0A7D3-EC71-4184-9C0C-AED6856023D2
P2860
Structural basis for the activation and inhibition of the UCH37 deubiquitylase.
description
2015 nî lūn-bûn
@nan
2015 թուականի Փետրուարին հրատարակուած գիտական յօդուած
@hyw
2015 թվականի փետրվարին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Structural basis for the activation and inhibition of the UCH37 deubiquitylase.
@ast
Structural basis for the activation and inhibition of the UCH37 deubiquitylase.
@en
type
label
Structural basis for the activation and inhibition of the UCH37 deubiquitylase.
@ast
Structural basis for the activation and inhibition of the UCH37 deubiquitylase.
@en
prefLabel
Structural basis for the activation and inhibition of the UCH37 deubiquitylase.
@ast
Structural basis for the activation and inhibition of the UCH37 deubiquitylase.
@en
P2093
P2860
P1433
P1476
Structural basis for the activation and inhibition of the UCH37 deubiquitylase.
@en
P2093
Benjamin Schmitt
Casey W Hemmis
Christopher P Hill
Frank G Whitby
Howard Robinson
Robert E Cohen
Ryan T Vander Linden
Tingting Yao
P2860
P304
P356
10.1016/J.MOLCEL.2015.01.016
P577
2015-02-19T00:00:00Z